Global Point of Care Lipid Test Market by Instruments (Brand Market Application (Hypertriglyceridemia, Brand Market By Application Hyperlipidemia) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Industry Insights

The global point-of-care Lipid Test market was worth USD 200.0 million in 2014. The key driver is the increasing prevalence of target diseases like diabetes and cardiovascular disease.

Favorable regulatory initiatives in diagnosis are expected to be a strong driving force for the point-of-care Lipid Test market. The introduction of Clinical Laboratory Improvement Amendments in the U.S. (CLIA), is expected to increase usage rates over the forecast period.

U.S. PoC Lipid Test Market Revenue by Application, 2015 - 2022 (USD million)

Cardiovascular disease is the leading cause for death worldwide and one of the most deadly disorders. In the past three decades, cardiovascular diseases have been the leading cause of death and morbidity worldwide. A report by the World Health Organization (WHO) estimates that cardiovascular diseases will result in approximately 23.3 million deaths per year by 2030.

Market growth is expected to be driven by a growing global geriatric population and increasing awareness over the next six-years. Demand will rise due to rising demand for technological advances that improve speed, accuracy and user-friendliness. Also, increasing market penetration rates for technologies like self-testing handheld devices, which are expected to increase, is expected to drive demand. Polymer Technology Systems Inc. released the CardioChek Plus, an advanced version of its point-of-care multi-analyte system in 2013. The manufacturers are likely to see a growing number of people who live sedentary lives and have unhealthy lifestyles.

Instrument Insights

Roche Reflotron and Roche Cobas b101, Abaxis Piccolo and Alere Cholestech LDx are the most commonly used instruments. They also form the heart of the study. In 2014, the PoC lipid testing market was worth more than USD 142 millions. It is projected to grow at a 10.5% CAGR over the forecast period.

Alere Cholestech LDX instruments can test lipid levels more accurately than the Alere Afinion analyzer. Alere Cholestech LDX was the company with the highest revenues of more than USD 55.1 million in 2014. Alere Cholestech LDX has many benefits. It is compact in design, requires very little blood sample (40 mL), performs fingerstick, does not require trained professionals, quick results, and no need for professional training. These factors will increase Cholestech LDX adoption for home use and daily lipid level testing.

Roche Cobas B101 will experience rapid growth and its market is projected grow at a CAGR 24.1% due to the expected global launch at the end 2012 of Cobas B101 (excluding U.S.A) for diagnosis and management metabolic disorders in point-of-care settings.

CLIA-exempted point of care molecular diagnostics as well as emerging technologies are the two main growth drivers for this market. The market for point-of-care Lipid Tests is expected to grow due to the increasing prevalence of Coronary Artery diseases (CAD), lifestyle choices such as smoking and excessive alcohol consumption, growing geriatric populations, and growing demand for efficient and quick healthcare management.

Application Insights

On the basis of application, the market is segmented into hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hyperlipoproteinemia, Tangier disease, and others.

The overall market was dominated by hyperlipidemia, with a revenue estimate of over USD 55.0 millions in 2014. This segment is largely driven by the rising prevalence of hyperlipidemia, a condition that can be caused by a high-fat diet and sedentary lifestyle, and the growing demand for point-of-care devices to manage chronic diseases like diabetes and cardiovascular disease.

Additionally, hypertriglyceridemia is expected to grow at a fastest CAGR (5.5%) over the next six-years, mainly due to the growing demand for point of care lipid testing, advanced tests in countries where there are high unmet clinical need such as Brazil, India, China, and China.

Regional Insights

Europe held the largest share of the global market in 2014 at 35%. This was due to favorable regulations and government initiatives pertaining to the construction of healthcare infrastructure and high levels of disease prevalence in the region.

Asia Pacific will show high potential to grow this market, with a CAGR exceeding 10% due to factors like favorable regulatory environment and growing population with diabetes and cardiovascular disease.

China, Australia and South Africa have experienced rapid economic growth in the last few years. These countries are expected offer enormous growth potential for PoC Lipid Test Industry, mainly because of their growing economies and high unmet medical needs.

Point of Care Lipid Test Market Share insights

This market is dominated by Roche Diagnostics, Abaxis Inc. and Alere Inc., Samsung Electronics Corporation, Polymer Technology Systems, and Samsung Electronics Corporation.

Due to the changing economic environment worldwide, market players are adopting sustainable strategies such as venture capital investments, new product development and mergers. In-vitro diagnostic technology and technology was launched by Samsung in India in 2013 under the name GEO. Samsung's LABGEOPT10 is designed to cater to India's lipid testing target audience.

These are the most frequently asked questions about this report

b. Global POC lipid market size was USD 244.4 Million in 2019, and is forecast to grow to USD 255.4 Million in 2020.

b. Global POC lipid market to reach USD 280.0 Million by 2027 is expected to grow at 4.4% compound annual growth rate from 2015 to 2022.

b. With a market share of 28.5%, hyperlipidemia dominated POC lipid testing in 2019, This is due to an increasing number of people suffering from hyperlipidemia, a condition that can be caused by a high-fat diet, sedentary lifestyle, and rising demand for point of care devices to manage chronic diseases like diabetes and cardiovascular disease.

b. Roche Diagnostics, Abaxis Inc. and Samsung Electronics Corporation are some of the key players in the POC Lipid Test Market.

b. The growth of the POC market for lipid tests is driven by the rising prevalence of target diseases like diabetes and cardiovascular disease, as well as the existence of regulatory initiatives that support the diagnosis.

Up Market Research published a new report titled “Point of Care Lipid Test Market research report which is segmented by Instruments (Brand Market Application (Hypertriglyceridemia, Brand Market By Application Hyperlipidemia), By Players/Companies Alere Inc, Roche Diagnostics, Abaxis Inc, Samsung Electronics Corporation, Polymer Technology Systems ”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Point of Care Lipid Test Market Report Segments:

The market is segmented by Instruments (Brand Market Application (Hypertriglyceridemia, Brand Market By Application Hyperlipidemia).

Point of Care Lipid Test Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Point of Care Lipid Test Market

Overview of the regional outlook of the Point of Care Lipid Test Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Point of Care Lipid Test Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Point of Care Lipid Test Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Hypertriglyceridemia

                2. Brand Market By Application Hyperlipidemia

7. Market scenario by region, sub-region, and country.
8. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
9. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
10. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Point of Care Lipid Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Point of Care Lipid Test Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.